Christopher Reyes
Chief Executive Officer at Bloom Science, Inc.
Profile
Christopher Reyes was the founder of Eclipse Therapeutics, Inc. which was founded in 2011, where he held the title of Director & Chief Scientific Officer.
Dr. Reyes is also the founder of Bloom Science, Inc. He previously worked as a Scientist at Biogen, Inc. Dr. Reyes received his undergraduate degree from the University of California, Berkeley and his graduate degree from The University of California, San Francisco.
Christopher Reyes active positions
| Companies | Position | Start |
|---|---|---|
Bloom Science, Inc.
 Bloom Science, Inc. Internet Software/ServicesTechnology Services Bloom Science, Inc. operates as a biotechnology company. It specializes in microbiome, epilepsy, clinical research, neurology, immunology, and oncology. The company was founded by Christopher Reyes, Elaine Hsiao, Raphael Valdivia, and Tony Colasin and in headquartered in San Diego, CA. | Chief Executive Officer | 31/12/2017 |
Former positions of Christopher Reyes
| Companies | Position | End |
|---|---|---|
| BIOGEN INC. | Corporate Officer/Principal | - |
Eclipse Therapeutics, Inc.
 Eclipse Therapeutics, Inc. BiotechnologyHealth Technology Eclipse Therapeutics, Inc. is a private biotechnology company dedicated to the discovery and development of therapeutics that target cancer stem cells and other forms of innovative cancer treatment. Cancer stem cells are a subset of cells within a tumor thought to play a critical role in tumor initiation, metastasis and recurrence. They are also implicated in resistance to current standard of care cancer treatments. Eclipse is leveraging its deep expertise in cancer stem cell biology and therapeutic antibodies to develop novel therapeutics that address unmet needs in cancer patient care. Eliminating cancer stem cells, in conjunction with other therapies that address the tumor bulk, represents a new cancer treatment paradigm that could offer a distinct advantage over existing strategies and a solution for chemo resistance. The company was founded in March 2011 by former Biogen Idec employees, Peter Chu, Christopher Reyes and Jonathan Lim and is headquartered in San Diego, CA. | Founder | - |
Training of Christopher Reyes
| University of California, Berkeley | Undergraduate Degree |
| The University of California, San Francisco | Graduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BIOGEN INC. | Health Technology |
| Private companies | 2 |
|---|---|
Eclipse Therapeutics, Inc.
Eclipse Therapeutics, Inc. BiotechnologyHealth Technology Eclipse Therapeutics, Inc. is a private biotechnology company dedicated to the discovery and development of therapeutics that target cancer stem cells and other forms of innovative cancer treatment. Cancer stem cells are a subset of cells within a tumor thought to play a critical role in tumor initiation, metastasis and recurrence. They are also implicated in resistance to current standard of care cancer treatments. Eclipse is leveraging its deep expertise in cancer stem cell biology and therapeutic antibodies to develop novel therapeutics that address unmet needs in cancer patient care. Eliminating cancer stem cells, in conjunction with other therapies that address the tumor bulk, represents a new cancer treatment paradigm that could offer a distinct advantage over existing strategies and a solution for chemo resistance. The company was founded in March 2011 by former Biogen Idec employees, Peter Chu, Christopher Reyes and Jonathan Lim and is headquartered in San Diego, CA. | Health Technology |
Bloom Science, Inc.
Bloom Science, Inc. Internet Software/ServicesTechnology Services Bloom Science, Inc. operates as a biotechnology company. It specializes in microbiome, epilepsy, clinical research, neurology, immunology, and oncology. The company was founded by Christopher Reyes, Elaine Hsiao, Raphael Valdivia, and Tony Colasin and in headquartered in San Diego, CA. | Technology Services |
- Stock Market
- Insiders
- Christopher Reyes
